UY31750A - Compuestos y composiciones como inhibidores de quinasa - Google Patents

Compuestos y composiciones como inhibidores de quinasa

Info

Publication number
UY31750A
UY31750A UY0001031750A UY31750A UY31750A UY 31750 A UY31750 A UY 31750A UY 0001031750 A UY0001031750 A UY 0001031750A UY 31750 A UY31750 A UY 31750A UY 31750 A UY31750 A UY 31750A
Authority
UY
Uruguay
Prior art keywords
compositions
compounds
quinasa
inhibitors
quinasa inhibitors
Prior art date
Application number
UY0001031750A
Other languages
English (en)
Inventor
Jiang Tao
Zhu Xuefeng
Pei Wei
Truc Ngoc Nguyen
Wu Baogen
Pierre Y Ves Michellys
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irm Llc filed Critical Irm Llc
Publication of UY31750A publication Critical patent/UY31750A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La invención se rediere a composiciones de triazina y pirimidina y mètodos para utilizar las composiciones de la Fórmula (1) o (2): donde R1, R2, R3, R4, R5, X Y, Z1, Ph, B m, n son como se los definió anteriormente.
UY0001031750A 2008-04-07 2009-04-03 Compuestos y composiciones como inhibidores de quinasa UY31750A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4311108P 2008-04-07 2008-04-07
US9588308P 2008-09-10 2008-09-10

Publications (1)

Publication Number Publication Date
UY31750A true UY31750A (es) 2009-12-14

Family

ID=40786670

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031750A UY31750A (es) 2008-04-07 2009-04-03 Compuestos y composiciones como inhibidores de quinasa

Country Status (13)

Country Link
US (1) US8518931B2 (es)
EP (1) EP2271645A1 (es)
JP (1) JP5214799B2 (es)
KR (1) KR20110002080A (es)
CN (1) CN102056925A (es)
AR (1) AR071300A1 (es)
AU (1) AU2009233963B2 (es)
BR (1) BRPI0910979A2 (es)
CA (1) CA2720944C (es)
EA (1) EA018484B1 (es)
MX (1) MX2010011069A (es)
UY (1) UY31750A (es)
WO (1) WO2009126514A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI389893B (zh) 2007-07-06 2013-03-21 Astellas Pharma Inc 二（芳胺基）芳基化合物
CA2723961C (en) 2008-05-21 2017-03-21 Ariad Pharmaceuticals, Inc. Phosphorous derivatives as kinase inhibitors
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
PL2428508T3 (pl) 2009-05-08 2016-05-31 Astellas Pharma Inc Diaminoheterocykliczny związek karboksyamidowy
WO2012097478A1 (en) * 2011-01-21 2012-07-26 Abbott Laboratories Bicyclic carboxamide inhibitors of kinases
CN103501612B (zh) 2011-05-04 2017-03-29 阿里亚德医药股份有限公司 抑制表皮生长因子受体导致的癌症中细胞增殖的化合物
WO2013169401A1 (en) 2012-05-05 2013-11-14 Ariad Pharmaceuticals, Inc. Compounds for inhibiting cell proliferation in egfr-driven cancers
EP2867233A1 (en) 2012-07-03 2015-05-06 Aurigene Discovery Technologies Limited 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
CN104854101B (zh) * 2012-11-06 2018-05-01 上海复尚慧创医药研究有限公司 Alk激酶抑制剂
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
CN103570728B (zh) * 2013-11-12 2015-12-30 山东大学 一种取代吡唑并[1,5-a]嘧啶类衍生物及其制备方法与应用
CA2940918C (en) * 2014-03-27 2023-10-24 Janssen Pharmaceutica Nv Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-.alpha.]pyrazine derivatives and 5,6,7,8-tetrahydro-4h-pyrazolo[1,5-.alpha.][1,4]diazepine derivatives as ros1 inhibitors
EP3778604A1 (en) * 2015-02-13 2021-02-17 Dana Farber Cancer Institute, Inc. Lrrk2 inhibitors and methods of making and using the same
JP7216705B2 (ja) 2017-07-28 2023-02-02 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用方法
CN110483526B (zh) * 2019-09-09 2021-10-01 辽宁大学 含芳基腙结构的吡唑并[1,5-a]嘧啶类衍生物及其应用
GB201915618D0 (en) 2019-10-28 2019-12-11 Univ Oslo ALK inhibitors for treatment of ALK-negative cancer and antibody-mediated diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7406641A (es) 1973-05-22 1974-11-26
EP1345941A1 (fr) 2000-12-20 2003-09-24 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
FR2842809A1 (fr) 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
KR20050033659A (ko) * 2002-09-04 2005-04-12 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 피라졸로[1,5-ａ]피리미딘 화합물
EP1599482A4 (en) * 2003-02-28 2008-10-01 Teijin Pharma Ltd PYRAZOLO1,5-A PYRIMIDINE DERIVATIVES
GB0305559D0 (en) * 2003-03-11 2003-04-16 Teijin Ltd Compounds
US20070179161A1 (en) * 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
US20070060595A1 (en) * 2003-10-10 2007-03-15 Toshio Yoshizawa Novel fused heterocyclic compound and use thereof
PE20051128A1 (es) 2004-02-25 2006-01-16 Schering Corp Pirazolotriazinas como inhibidores de quinasa
JP2006160628A (ja) 2004-12-03 2006-06-22 Ishihara Sangyo Kaisha Ltd アデノシンＡ２ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
JP2008524330A (ja) * 2004-12-21 2008-07-10 シェーリング コーポレイション ピラゾロ［１，５−Ａ］ピリミジンアデノシンＡ２ａ受容体アンタゴニスト
US7723336B2 (en) 2005-09-22 2010-05-25 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
US7517882B2 (en) * 2006-09-18 2009-04-14 Polaris Group Protein kinase inhibitors
WO2008057402A2 (en) 2006-11-02 2008-05-15 Cytovia, Inc. N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof

Also Published As

Publication number Publication date
CA2720944A1 (en) 2009-10-15
JP2011516554A (ja) 2011-05-26
JP5214799B2 (ja) 2013-06-19
AR071300A1 (es) 2010-06-09
EA018484B1 (ru) 2013-08-30
CN102056925A (zh) 2011-05-11
MX2010011069A (es) 2010-11-12
CA2720944C (en) 2012-12-18
US8518931B2 (en) 2013-08-27
BRPI0910979A2 (pt) 2016-01-05
EA201001596A1 (ru) 2011-04-29
KR20110002080A (ko) 2011-01-06
US20110190264A1 (en) 2011-08-04
AU2009233963B2 (en) 2011-10-06
WO2009126514A1 (en) 2009-10-15
WO2009126514A8 (en) 2010-10-21
AU2009233963A1 (en) 2009-10-15
EP2271645A1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
UY31750A (es) Compuestos y composiciones como inhibidores de quinasa
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
UY32366A (es) Compuestos de amidina sustituida para combatir plagas de animales
CR11492A (es) Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i
EA200901529A1 (ru) Производные арилоазол-2-илцианоэтиламина, способ их получения и способ их применения
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
CR20120121A (es) Compuestos de benzoxazepina como inhibidores de la pi3k y métodos de uso
BRPI0511933A (pt) derivados de quinazolinona úteis como antagonistas de vanilóide
EA201190227A1 (ru) Оксазолзамещенные индазолы в качестве ингибиторов pi3-киназ
UY29612A1 (es) Compuestos quimicos ii
ECSP088145A (es) Derivados bicíclicos como inhibidores de la cinasa p38
CO6551705A2 (es) Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina
EA201170282A1 (ru) Фунгицидные n-циколоалкил-n-бифенилметилкарбоксамидные производные
CY1112829T1 (el) Νεα μεθοδος συνθεσης για την αγομελατινη
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
MX2015013365A (es) Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag).
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
UY30545A1 (es) Derivados sustituidos del acido acilamino-benzoico, composiciones que los contienen y aplicaciones
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181025